Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples